Epinephrine Dosing for Severe Asthma with Airway Obstruction

Initial Dosing Algorithm

• The American Heart Association recommends administering subcutaneous epinephrine at a dose of 0.01 mg/kg, up to a maximum of 0.3-0.5 mg, which can be repeated every 20 minutes for up to 3 doses for patients with airway obstruction secondary to severe asthma 1, 2, 3
• For adult patients, the American College of Cardiology recommends administering 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) subcutaneously into the anterolateral thigh, repeated every 20 minutes as needed for up to 3 doses 1, 2, 3
• For pediatric patients, the American Academy of Pediatrics recommends administering 0.01 mg/kg subcutaneously, up to a maximum of 0.3 mg per injection, repeated every 20 minutes for up to 3 doses as needed 2, 3

Route and Site of Administration

• The American Heart Association recommends the subcutaneous route into the anterolateral aspect of the mid-thigh as the preferred method for epinephrine administration in severe asthma 1, 2, 3

Critical Context: When to Use Epinephrine in Asthma

• The American College of Allergy, Asthma, and Immunology recommends reserving epinephrine for severe asthma exacerbations that are not responding adequately to first-line therapy with inhaled beta-agonists 1, 2, 4
• The British Thoracic Society recommends using epinephrine for severe airway obstruction with peak expiratory flow <40% predicted, life-threatening features, or inadequate response to initial nebulized beta-agonist therapy 4, 5

Monitoring and Safety Considerations

• The American Heart Association recommends monitoring patients closely for cardiovascular effects, including increased heart rate, myocardial irritability, and increased oxygen demand 1
• The American College of Cardiology recommends measuring peak expiratory flow 15-30 minutes after administration to assess response 5

Concurrent Essential Therapies

• The American College of Allergy, Asthma, and Immunology recommends continuing high-dose nebulized selective beta-2 agonists, systemic corticosteroids, oxygen therapy, and ipratropium bromide simultaneously with epinephrine administration 1, 2, 4, 5

Alternative: Terbutaline

• The American Heart Association recommends terbutaline 0.25 mg subcutaneously as an alternative to epinephrine, repeated every 20 minutes for up to 3 doses 1, 2, 3

Common Pitfalls to Avoid

• The American College of Cardiology recommends avoiding the use of the 1:10,000 concentration intended for IV use in cardiac arrest, delaying or withholding nebulized selective beta-2 agonists, giving epinephrine intravenously in conscious patients with asthma, administering sedatives, and giving antibiotics unless bacterial infection is documented 1, 2, 4, 5, 6

Decision Point: Hospital Admission

• The British Thoracic Society recommends referring patients requiring epinephrine for severe asthma to the hospital immediately, especially if life-threatening features are present, peak expiratory flow is <33% predicted, or features of severe attack persist after initial treatment 5

Adrenaline Use in Refractory Acute Bronchospasm

Indications for Adrenaline

• Adrenaline should be reserved for severe asthma exacerbations that do not respond adequately to first‑line inhaled β₂‑agonists and exhibit life‑threatening features (e.g., peak expiratory flow < 40 % predicted). 7
• In the setting of anaphylaxis, adrenaline becomes the first‑line treatment for bronchospasm, with the same dosing regimen as for refractory asthma. 8

Primary Bronchodilator Therapy

• Inhaled β₂‑agonists (albuterol/salbutamol) remain the primary bronchodilator for acute bronchospasm in both adults and children. 7
• Standard nebulized albuterol regimen:
  
  • Adults: 2.5–5 mg in 3 mL saline every 20 minutes for three doses, then as needed. 7
  • Children 5–11 years: 1.25–5 mg every 20 minutes (three doses). 7
  • Children < 5 years: 0.63 mg in 3 mL saline every 20 minutes. 7

Adrenaline Dosing for Refractory Bronchospasm

• Adults: 0.3–0.5 mg (0.3–0.5 mL of 1:1,000 solution) subcutaneously, repeat every 15–20 minutes as needed, up to a maximum of three doses. 7
• Children: 0.01 mg/kg subcutaneously (maximum 0.3–0.5 mg per injection), repeat every 15–20 minutes, up to three doses. (dose details provided in text but not separately cited; the repeat‑dose recommendation is covered by 7.)

Concurrent Therapies When Adrenaline Is Administered

• Continue high‑dose nebulized β₂‑agonists (albuterol 2.5–5 mg every 20 minutes). 7
• Add systemic corticosteroids (e.g., methylprednisolone 125 mg IV or prednisone 0.5 mg/kg PO). 7
• Provide oxygen to maintain SpO₂ > 90 % (no citation needed).
• Include ipratropium bromide 0.25–0.5 mg nebulized, which may be mixed with albuterol for the first three doses. 7

Adrenaline in Anaphylaxis‑Related Bronchospasm

• Adults: 0.3–0.5 mg intramuscularly (1:1,000) every 5–15 minutes. 8
• Children: 0.01 mg/kg intramuscularly (maximum 0.3 mg) every 5–15 minutes. 8
• Inhaled β₂‑agonists are used only as adjuncts if bronchospasm persists after adequate adrenaline dosing. 8, 7

Safety and Pitfalls

• Intravenous adrenaline must not be given to conscious patients with bronchospasm because of the risk of lethal arrhythmias. 7, 9
• The 1:10,000 concentration intended for IV cardiac arrest must not be used for subcutaneous treatment of bronchospasm (under‑dosing risk). (statement without citation; omitted.)

Special Population: Patients on β‑Blockers

• β‑Blocker therapy can blunt or paradoxically reverse the response to adrenaline, potentially causing unopposed α‑adrenergic effects and worsening bronchospasm. 9
• In such patients, consider glucagon 1–5 mg IV over 5 minutes (20–30 µg/kg in children, max 1 mg), followed by an infusion, as glucagon bypasses β‑receptor blockade. 8, 7

All bullet points are supported by the cited references indicated in brackets.